Journal Phlebology and Lymphology

ISSN:1983-8905-volume 4, 2011






Instructions for Authors
Journal Phlebology and Lymphology is an Open Access online journal, which publishes Research articles, Reviews and Letters in the field of cardiovascular medicine, aiming at providing the most complete and reliable source of information on current developments in the field.

Online Manuscript Submission: To facilitate rapid publication the Journal Phlebology and Lymphology accepts only online submission. The full manuscript has to be submitted: http://www.digitalmedicaljournals.com/

Any manuscripts, or substantial parts of it, submitted to the journal must not be under consideration by any other journal. In general, the manuscript should not have already been published in any journal or other citable form. The principal/corresponding author will be required to submit a Covering Letter along with the manuscript, on behalf of all the co-authors (if any). Furthermore, any illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained. all authors have read and agreed to its content, and that any experimental research that is reported in the manuscript has been performed with the approval of an appropriate ethics committee. Research carried out on humans must be in compliance with the Helsinki Declaration.

For all online submissions, please provide users word processing. Note that figures/illustrations must be submitted as separate image files.


Manuscript Preparation: The manuscript should be written in English in a clear, direct and active style. All pages must be numbered sequentially.


Manuscript Sections:


Letters: The maximum total page length for Letter type articles published in the journal is nine journal pages. Each journal page is on average 900 words.

Research Articles: The minimum total page length for Research articles is ten journal pages, and the maximum thirty pages. Each journal page is on average 900 words.

Review Articles: The maximum page length limit for comprehensive Review articles is forty pages. For Mini-Review articles, the maximum page length is nine journal pages. Each journal page is on average 900 words.

There is restriction on the number of figures (3 maximum), tables (3 maximum) or additional files e.g. video clips (1maximum), that can be included with each article online.



Requirements

Covering letter
Title page
Abstract
Text organization
List of abbreviations (if any)
Conflict of interest (if any)
Acknowledgements (if any)
References
Figures/illustrations (if any)
Tables and captions (if any)
Supportive/supplementary material (if any)


COVERING LETTER: covering letter also be submitted with the manuscript by the author to whom correspondence is to be addressed declaring the potential competing interests, acknowledging contributions from authors and funding agencies, and certifying that the paper is prepared according to the 'Instructions for Authors'. The authors acknowledge that the publishers have the legal right to take appropriate action against the authors for any such violation of the terms and conditions as laid down in the agreement.

TITLE: The title should be precise and brief and must not be more than 120 characters.

ABSTRACT: The abstract should not exceed 250 words for review and research papers and should be limited to only 150 words for letters. Structured into separate sections: Aim, Method, Results, Conclusion and Trial registration, if your research article reports the results of a controlled health care intervention, please list your trial registry, along with the unique identifying number, e.g. Trial registration: Current Controlled Trials ISRCTN73824458. Please note that there should be no space between the letters and numbers of your trial registration number.


TEXT ORGANIZATION:

Research articles: the preparation of the main text must be structured into separate sections as Introduction, Method, Results, Discussion, Conclusion and Trial Registration.

For Review and Letter articles: the manuscript should be divided into title page, abstract and the main text and Reference sections.

***Trial Registration. The International Committee of Medical Journal Editors (ICMJE) defines a clinical trial as any research study that prospectively assigns human subjects to one or more health related interventions to evaluate the effects on health outcomes. Authors of protocols or reports of such clinical trials, where the primary purpose of the research is to understand the causes, development and effects of disease, or to improve preventative, diagnostic or therapeutic interventions, must register their trial prior to submission in a suitable publicly accessible registry. Registries which meet the requirements of the ICMJE include WHO Primary Registries. The trial registration number should be included as the last line of the abstract of the manuscript

Ethical Approval of Studies and Informed Consent: For human or animal experimental investigations, it is a prerequisite to provide a formal review and approval by an appropriate institutional review board or ethics committee and should be documented in your paper. For investigations with human subjects should obtain the consent of the patient (oral or written) to use the study material including photographs and report on the session method. The Journal Phlebology and Lymphology ask you to send a signed consent form before publication. Consent must be obtained for all Case Reports and Clinical Pictures.


LIST OF ABBREVIATIONS: If abbreviations are used in the text either they should be defined in the text where first used, or a list of abbreviations can be provided.

CONFLICT OF INTEREST: Financial contributions to the work being reported should be clearly acknowledged by all authors.

ACKNOWLEDGEMENTS: Please acknowledge anyone who contributed towards the study by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include their source(s) of funding. Please also acknowledge anyone who contributed materials essential for the study. The role of a medical writer must be included in the acknowledgements section, including their source(s) of funding. Authors should obtain permission to acknowledge from all those mentioned in the Acknowledgements.

IMPORTANT
This journal complies with the International Committee of Medical Journal Editors' Uniform Requirements for Manuscripts Submitted to Biomedical Journals www.icmje.org and the FDA's Good Reprint Practices for the Distribution of Medical Journal Articles and Medical or Scientific Reference Publications on Unapproved New Uses of Approved Drugs and Approved or Cleared Medical Devices http://www.fda.gov/oc/op/goodreprint.html

REFERENCES: All references must be numbered consecutively in the order in which they are cited in the text. Examples of the Journal Phlebology and Lymphology reference style are shown below (Vancouver Style).

Article: 1- Okarvi SM, Al Jammaz I. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors. Nucl Med Biol. 2010; 37(3):277-288.
2- Caprini JA. Stockings or no stockings: that is the question. Ann Surg. 2010; 251(3):397-8.

Book Chapter: 3- Schnepf E: From prey via endosymbiont to plastids: comparative studies in dinoflagellates. In Origins of Plastids. Volume 2. 2nd edition. Edited by Lewin RA. New York: Chapman and Hall; 1993:53-76.

Book Reference: 4- Margulis L: Origin of Eukaryotic Cells. New Haven: Yale University Press; 1970.

Conference Proceedings: 6- Jones X: Zeolites and synthetic mechanisms. In Proceedings of the First National Conference on Porous Sieves: 27-30 June 1996; Baltimore. Edited by Smith Y. Stoneham: Butterworth-Heinemann; 1996:16-27.

Citation in Internet: 7- The Mouse Tumor Biology Database [http://tumor.informatics.jax.org/mtbwi/index.do]

FIGURES/ILLUSTRATIONS: Figures should be provided as separate files and should not be included in the main text of the submitted manuscript. The legend should be included.

Formats:
• EPS (preferred format for diagrams)
• PDF (also especially suitable for diagrams)
• PNG (preferred format for photos or images)
• Microsoft Word ( figures must be a single page)
• JPEG (conversion should be done using the original file)
***Please note that it is the responsibility of the author(s) to obtain permission from the copyright holder to reproduce figures or tables that have previously been published elsewhere.



TABLES:
*Data Tables should be submitted in Microsoft Word, separated file but cited in the text. *Table number in Calibri font 12. Table 1, should follow a title. *Tables should be embedded in the text exactly according to their appropriate placement in the submitted manuscript.


SUPPORTIVE/SUPPLEMENTARY MATERIAL: We do encourage presentation supportive material used, a video, or the original data provided it is inevitable or endorsed by the journal's Editor. The material requires written permission. Any additional files will be linked into the final published article. and the material can not exceed 3MB. For obtaining permission for reproducing any material published in an article by Journal Phlebology and Lymphology, please fill in the request PERMISSION FORM and send to Journal.

PUBLICATION AND PEER REVIEW PROCESS Journal Phlebology and Lymphology uses online peer review to speed up the publication process. The time taken to reach a final decision depends on whether reviewers request revisions.

PROOF

Manuscript accepted the author will receive a proof for corrections to be returned in 48 hours. If in 48 hours the author does not return the proof the article will be published exactly as received and the publishers the Journal Phlebology and Lymphology not be responsible for any error occurring in the manuscript in this regard.

COPYRIGHT: Authors who publish in Journal Phlebology and Lymphology retain copyright to their work. Submission of a manuscript to the respective journals implies that all authors have read and agreed and signed to the content of the Covering Letter or the Terms and Conditions.
COPYRIGHT FORM